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Aspergillus fumigatus is a human opportunistic pathogen showing
emerging resistance against a limited repertoire of antifungal
agents available. The GTPase Rho1 has been identified as an impor-
tant regulator of the cell wall integrity signaling pathway that reg-
ulates the composition of the cell wall, a structure that is unique to
fungi and serves as a target for antifungal compounds. Rom2, the
guanine nucleotide exchange factor to Rho1, contains a C-terminal
citron homology (CNH) domain of unknown function that is found
in many other eukaryotic genes. Here, we show that the Rom2 CNH
domain interacts directly with Rho1 to modulate β-glucan and chitin
synthesis. We report the structure of the Rom2 CNH domain, reveal-
ing that it adopts a seven-bladed β-propeller fold containing three
unusual loops. A model of the Rho1–Rom2 CNH complex suggests
that the Rom2 CNH domain interacts with the Rho1 Switch II motif.
This work uncovers the role of the Rom2 CNH domain as a scaffold
for Rho1 signaling in fungal cell wall biosynthesis.
Aspergillus fumigatus | structural biology | signal transduction | cell wall |
citron homology domain
Fungal diseases are a major cause of morbidity in immuno-compromised patients. Aspergillus fumigatus, the causative
agent of invasive aspergillosis, is one of the deadliest invasive
pathogenic fungi (1). There is a limited repertoire of therapeutic
agents available to treat aspergillosis. These include the azoles,
which disrupt the synthesis of the fungal membrane by targeting
the ergosterol biosynthetic pathway (2, 3); polyenes, which bind
directly to ergosterol affecting cell membrane integrity (4, 5);
echinocandins, which target cell wall stability by inhibiting glucan
synthesis (6, 7); and nucleotide analogs like 5-flucytosine, which
hamper fungal DNA synthesis (8). Among them, the azoles vor-
iconazole and isavuconazole are the preferred antifungal treat-
ment for invasive aspergillosis due to their lower toxicity and their
higher fungicidal activity (9). However, the emergence of azole-
resistant strains provides an impetus for the search of novel targets
within pathways that are essential for A. fumigatus survival (10).
The fungal cell wall is a highly ordered carbohydrate-rich
structure that is not present in human cells but is essential for
protecting fungi from challenging environmental factors such as
mechanical stress, temperature changes, osmotic stress, pH, and
nutrient limitations (11). In addition, the cell wall also mediates
host-pathogen interactions that are critical during infection (12).
Therefore, the fungal cell wall is considered as a potential source
of selective antifungal targets that are unlikely to affect human
cells. The 1,3-β-glucan is a major A. fumigatus cell wall component
that contributes up to 20% to 35% of the cell wall biomass (13).
Other components of the A. fumigatus cell wall are α-glucan,
chitin, galactomannan, and a mixed 1,4-β-/1,3-β-glucan layer (13).
The fungal cell wall is highly dynamic with changeable compo-
nents to counteract different types of stresses. This response is
mainly mediated by the cell wall integrity (CWI) signaling pathway
in which the Rho-type GTPase homologous 1 (Rho1) protein is a
key node (14, 15). The cell membranes of Rho1 mutants in Sac-
charomyces cerevisiae, Candida albicans, and A. fumigatus were
found to be defective in the activity of the plasma membrane 1,3-
β-glucan synthase (GS) enzyme, which was rescued by the addition
of purified Rho1 (7, 16). Apart from direct binding and subse-
quent activation of the 1,3-β-GS, Rho1 was also shown to modu-
late different downstream effectors in budding yeast, including the
transcription factor Rlm1 that controls the expression of genes
involved in cell wall biosynthesis (14, 15). Furthermore, knock-
down of A. fumigatus rho1 induces lethality through cell lysis (17).
Taken together, these studies show that Rho1 activity is critical for
fungal survival.
Upstream of Rho1 are the GTP exchange factor proteins
(GEFs) Rom1 and Rom2, which, despite their high degree of
homology, induce very different phenotypes in knockout exper-
iments. Rom1 is dispensable, whereas the loss of Rom2 induces
cell lysis at high temperatures in S. cerevisiae (18). In A. fumi-
gatus, complete loss of Rom2 (AfRom2) results in a lethal phe-
notype (19). At the cellular level, Rom2 integrates signals from
cell wall stress sensors such as Wsc1-3, Mid1, and Mtl1 to acti-
vate Rho1 (14, 15). Furthermore, the subcellular localization of
GEFs is directly correlated with their function in different sig-
naling pathways (20). Similar to the reported subcellular locali-
zation of the fission yeast Rom2 homolog protein Rgf1p (21),
AfRom2 is found at the hyphal tips where it colocalizes with
AfRho1 (19). These findings suggest a prominent role of the
AfRom2–AfRho1 interaction in fungal cell wall biogenesis.
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AfRom2 is a multidomain protein (Fig. 1), containing a
Dishevelled, Egl-10, and Pleckstrin (DEP) domain that nega-
tively regulates its activity (19), a Dbl Homology (DH) domain
that facilitates GDP exchange (20, 22), and a Pleckstrin Ho-
mology (PH) domain that interacts with the DH domain and
contributes to GEF activity (19, 21, 22). In addition, it possesses
a C-terminal citron homology (CNH) domain whose exact
function remains unknown, but it has been proposed to interact
with either proteins (19, 23–25) or lipids, directing, as a conse-
quence, the cellular location (26).
Here, we use a multidisciplinary approach to uncover the roles
of the CNH domain as a driver for the AfRom2 cellular locali-
zation and as a scaffold for Rho1 GTPase signaling. We show
that the Rom2 CNH domain is critical for A. fumigatus cell wall
synthesis and stabilizes the 1,3-β-glucan synthesis regulator AfRho1.
We report a crystal structure of a eukaryotic CNH domain, re-
vealing that it adopts a seven-bladed β-propeller fold. Together with
the crystal structure of AfRho1 in complex with GDP, we identify
the putative AfRom2 CNH-AfRho1 binding interface, involving a
contribution of the AfRho1 Switch II motif. This work describes the
function of AfRom2 CNH as a scaffold for AfRho1 signaling and its
essential role in cell wall synthesis.
Results
AfRom2 Possesses a C-Terminal CNH Domain of Unknown Function.
Analysis of the AfRom2 (UniProt ID Q4WUI2) primary se-
quence reveals the presence of the autoinhibitory N-terminal DEP
domain (amino acids 330 to 405), the coupled DH and PH do-
mains, sometimes referred simply as GEF domain (19) (amino
acids 499 to 851), and a CNH domain (amino acids 881 to 1170)
(Fig. 1). In Drosophila melanogaster, the CNH domain does not
appear to be involved in the cellular localization of Sticky/Citron
kinases but is required to interact with Rho GTPase via unknown
mechanisms (25). Due to the limited (<20%, SI Appendix, Fig.
S1A) sequence identity between the AfRom2 CNH and the D.
melanogaster CNH domains, it is unclear if this interaction is
conserved in A. fumigatus. In contrast, fungal Rom2 CNH do-
mains are highly conserved (SI Appendix, Fig. S1B) but are absent
from Rho GEFs in higher eukaryotes (Fig. 1). In summary, in
silico analysis reveals that AfRom2 possesses a C-terminal CNH
domain conserved in fungi.
The CNH Domain Contributes to Growth and CWI. To investigate the
function of the CNH domain in AfRom2, a GFP-tagged rom2
mutant with the CNH domain replaced by gfp and the orotidine
5′-phosphate decarboxylase (pyrG) selection marker was con-
structed and verified by PCR (Fig. 2 A and B) and Southern
blotting (Fig. 2C). The resulting mutant strain is hereafter re-
ferred to as rom2Δcnh. To confirm expression of AfRom2, a GFP
antibody was used to detect the truncated GFP-fused AfRom2 in
the cell lysate from parental and mutant strains. There was no
detectable GFP antibody signal in the parental strain, but a 70 kDa
band was detected in the mutant lysate, corresponding to the size
of AfRom2ΔCNH (44 kDa) fused with GFP (27 kDa) (Fig. 2D).
Conidia of the parental and mutant strains were inoculated
onto solid yeast extract peptone dextrose (YEPD) media to ex-
plore colony growth phenotypes. After 48 h growth at 37 °C, the
colony diameter of the rom2Δcnh mutant was reduced when
compared to the parental strain, and almost no surface conidia
were produced by the mutant (Fig. 2E). This finding suggests
that the AfRom2 CNH domain is required for normal colony
growth and conidia production.
We next generated GFP fusions for the isolated CNH domain
and full length rom2, integrated into the A. fumigatus genome
under control of the constitutive gpd promoter (27). Constructs
were verified by PCR and western blotting (SI Appendix, Fig.
S3 B and C). The localization experiments (SI Appendix, Fig.
S2A) show that AfRom2 localizes to the cell membrane, enriched
at the hyphal tips where the new cell wall is synthesized, in
agreement with a previous study by Dichtl et al. (28). However,
in the absence of the CNH domain, AfRom2ΔCNH shows a
diffuse distribution in the cytoplasm. Interestingly, the overex-
pressed, isolated CNH domain localizes to the hyphal tips, sug-
gesting that AfRom2 cellular localization is dependent on its
C-terminal CNH domain (SI Appendix, Fig. S2A).
We next studied the role of AfRom2 CNH domain in regu-
lating cell wall biogenesis as reported for the full rom2 gene (19).
Serial dilutions of rom2Δcnh mutant and parental strain conidia
were inoculated on solid minimal media (MM) supplemented
with cell wall–perturbing agents (Fig. 3A). After 48 h growth at
37 °C, the rom2Δcnhmutant showed increased sensitivity to most
cell wall–perturbing agents when compared to the parental strain
(Fig. 3A). Taken together, these data suggest that the CNH
domain contributes to growth and CWI.
The CNH Domain Is Required for Cell Wall Synthesis. We next in-
vestigated whether the sensitivity of the rom2Δcnh mutant to cell
wall–perturbing agents was the result of a compromised cell wall.
Transmission electron microscopy (TEM) was used to examine
possible cell wall ultrastructure defects (Fig. 3B). Compared to
the parental strain, the rom2Δcnh mutant shows ∼20-fold re-
duction in the thickness of the middle region of the cell wall
(15 ± 4 nm for the mutant versus 290 ± 30 nm for the parental
strain [n ≥ 12]) and an associated detachment of the outer layer
(Fig. 3C and SI Appendix, Fig. S2 B and C).
To investigate the source of this structural defect, we next
quantified cell wall carbohydrate components. In agreement with
our TEM findings, levels of β-glucan, representing the middle
bulk layer of the cell wall, decreased more than 10-fold from
2,100 ± 50 μg/10 mg in the parental strain to only 180 ± 40 μg/
10 mg in the rom2Δcnh mutant (P < 0.0001, Student’s t test, n =
3, Fig. 3C). Furthermore, levels of chitin also decreased from
620 ± 40 μg/10 mg in the parental strain to 220 ± 40 μg/10 mg in
the rom2Δcnhmutant (P < 0.001, Student’s t test, n = 3, Fig. 3C).
Glycoprotein and α-glucan levels were unaffected (Fig. 3C).
These data suggest that the AfRom2 CNH domain is required
for cell wall synthesis, affecting levels of the key fungal cell wall
components β-glucan and chitin.
The CNH Domain Interacts with AfRho1. To identify the mechanism
underpinning the role of the AfRom2 CNH domain in regulating
cell wall synthesis, we employed a pull-down assay to identify
potential CNH binding partners using the GFP-tagged cnh
construct integrated into the A. fumigatus genome (SI Appendix,
Fig. S3A). A gfp construct integrated into the genome under
Fig. 1. Schematic representation (not to scale) of AfRom2 and comparison
with other GEF proteins. Identified domains: DEP domain, phorbol esters/
diacylglycerol binding domain (C1), DH domain, PH domain (20), and CNH
domain from A. fumigatus (AfRom2 Uniprot Q4WUI2) and human, Dro-
sophila, mouse, and zebrafish Rho GEF proteins (Uniprot codes: Q92974,
Q9VS45, Q5SSL4, and A5 × 7A1, respectively) are annotated in the figure.
The residues that define the boundaries of the DEP, DH, PH, and CNH do-
mains are indicated for clarity.
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control of the same gpd promoter was used as a negative control
(SI Appendix, Fig. S3D). We identified 1,236 proteins that
uniquely bind GFP-CNH domain compared to the GFP control
strain (SI Appendix, Fig. S3E and Dataset S1). Gene Ontology
(GO) enrichment analyses identified that the CNH mainly binds
membrane (GO ID: 16020, 27.6%) and plasma membrane (GO
ID: 5886, 10.5%) proteins, which is in line with the reported
cellular localization of Rom2 and our localization experiments.
Of note, we observed cytoskeletal proteins (GO ID: 5856, 3.9%)
and several proteins involved in actin regulation, such as End3,
the actin-related protein 4, and Pan1. Additionally, 37 of the
detected proteins are components of the cell wall, supporting the
phenotype seen in the rom2Δcnh mutant (Dataset S1). Among
these, we identified key proteins belonging to the CWI signaling
pathway, including Rho1, MidA, and Fks1.
Given that Rho1 has a key role in regulating glucan synthesis
(29), we next used biolayer interferometry (BLI) to further in-
vestigate the interaction between AfRho1 and AfRom2 CNH.
We used recombinant AfRom2 CNH as the stationary phase to
measure affinity toward recombinant AfRho1 in the presence or
absence of GDP or the nonhydrolysable GTP analog GTPγS.
These experiments revealed dose-dependent binding to AfRom2
CNH with Kds in the midmicromolar range (SI Appendix, Fig.
S4). Taken together, these data suggest a direct interaction be-
tween the AfRom2 CNH domain and AfRho1.
The CNH Domain Possesses a Unique β-Propeller Fold. There is cur-
rently no structure of any CNH domain available to aid in gen-
erating hypotheses on the nature of the AfRom2 CNH-AfRho1
interaction. We used X-ray crystallography to determine the protein
structure of the recombinantly produced AfRom2 CNH domain
(residues 862 to 1194) using a selenomethionine phasing strategy.
Crystals belonging to the orthorhombic space group P21212 with a
single molecule in the asymmetric unit diffracted to a maximum of
2.0 Å. The structure was refined to the maximum available reso-
lution with R and Rfree values of 20.7% and 24.7%, respectively.
Data collection and refinement parameters are listed in Table 1.
The AfRom2 CNH domain structure adopts a canonical
β-propeller fold containing seven blades, each composed of four
antiparallel strands (30). The seven blades are connected by
small loops and arranged in a circular fashion, with the last blade
formed by the N-terminal and C-terminal strands providing ad-
ditional stability through an extra zipper of hydrogen bonds
(Fig. 4A). A structural homology search with the Dali server (31)
identified the bacterial β-propeller protein YncE (rmsd = 2.8 Å
Fig. 2. Generation of a rom2Δcnh mutant. (A) Schematic diagram depicting the strategy for generation of the mutant. (B) PCR confirmation of rom2Δcnh
mutants. Primer pairs of P7-P8 and P9-P10 were used to amplify the rom2C and gfp-pyrG fragments, respectively. Primer pairs of P11-P12 and P13-P14 were
used to amplify regions of −500 bp to +500 bp of homologous arms when correctly integrated into the rom2C locus. (C) Southern blot confirmation of the
rom2Δcnh mutants. Genomic DNA was digested by XhoI and hybridized using the rom2M homologous region as the probe. (D) Western blot confirmation
using the GFP antibody from cell lysate of the wild-type (WT) and rom2Δcnhmutants. Cell lysate of a control strain gpd-gfp was used as control. The band size
from the rom2Δcnh (72 kDa) strain represents the correct molecular weight of AfRom2ΔCNH (44 kDa) with GFP fusion (27 kDa). (E) Growth of the rom2Δcnh
mutant in comparison with the parental strain on solid YEPD medium. The 100 conidia from the Afrom2Δcnh mutant and the parental strain were inoculated
on YEPD plates and incubated at 37 °C for 48 h.
Bartual et al. PNAS | 3 of 10































on 273 Cα atoms, Z value = 21.2) and the apoptotic protease
activating factor 1 (rmsd = 3.1 Å on 271 Cα atoms, Z value = 20.7)
to be the closest AfRom2 CNH structural homologs (SI Appendix,
Fig. S5A), albeit with poor conservation of sequence (12% and 8%
sequence identity, respectively). This discrepancy between se-
quence and structural homology is common for β-propeller folds
(32). Interestingly, the AfRom2 CNH blades are stapled together
by a unique complex network of leucine and isoleucine hydro-
phobic interactions, which deviates from the main β-propeller
stapling motifs, such as the WD40 motif, the KELCH motif, or
the YWTD motif (30) (SI Appendix, Fig. S5B). The insertion of a
disordered loop between blades 1 and 2 (named L1) and two long
loops containing a short helical domain between the strands C and
D from blades 2 and 5 (named L2 and L3, respectively) changes
the overall shape of the AfRom2 CNH domain to be oval rather
than circular (Fig. 4 A and B and SI Appendix, Fig. S5A). This
results in a cross-propeller diameter 1.5 times larger than the di-
ameter along the propeller axis. Similar to the structural homolog
YncE, the presence of the α-helical insertions may confer specific
functions (33). Interestingly, sequence alignments suggest that
these insertions are also present in other CNH domain proteins,
including the Drosophila GEFs and H. sapiens citron kinases (SI
Appendix, Fig. S5A). Taken together, the structural data show that
the CNH domain possesses a unique β-propeller fold.
The Switch II Region Is a Potential Interface in the AfRho1–AfRom2
CNH Interaction. To shed light on the observed AfRom2 CNH-
AfRho1 interaction, we attempted to obtain crystals of the
AfRom2 CNH-AfRho1 complex, but this was not successful. To
aid in subsequent modeling experiments, we determined the
structure of AfRho1 and obtained crystals in the presence of GDP
or GTPγS. Initial phases were determined using the structure of the
human GTPase RhoA (HsRhoA, PDB ID: 1FTN, 75% sequence
Fig. 3. Sensitivity to chemical reagents and cell wall analysis of the rom2Δcnh mutant. (A) Serial dilutions of conidia from 107 to 104 were spotted onto
solid MM containing 50 μg/mL Calcofluor White, 50 μg/mL Congo Red, and 2.5 μg/mL Caspofungin. The colonies were grown at 37 °C for 48 h. The con-
centrations of the chemicals were chosen as described previously (74). The photographs display representatives of three independent experiments. (B) TEM
images of representative parental (75) and rom2Δcnh mutant hyphal cells. (C) Cell wall width measurement of the rom2Δcnh mutant compared to the
parental strain (n > 20) and cell wall composition of the rom2Δcnhmutant compared to the parental strain by chemical analysis (56). The plots of the data and
the P values by the multiple t tests were calculated using Prism 6 (GraphPad software). The experiment was performed in triplicate.
4 of 10 | PNAS Bartual et al.























identity with AfRho1) as a phase donor in a molecular replacement
experiment (34). Data collection and refinement statistics are shown
in Table 1. The overall structure of AfRho1 has a typical Rho
GTPase fold, containing a core β-sheet flanked by α-helices (Fig.
4C). GDP, GTPγS, and the magnesium cofactor were fully defined
by unbiased Fo-Fc electron density maps (SI Appendix, Fig. S6A). In
both structures, the nucleotide sits in a positively charged conserved
pocket containing Lys18, Asp120, and Arg162, which form interac-
tions with the phosphate groups (SI Appendix, Fig. S6A).
Similar to the structure of HsRhoA (rmsd = 1.2 Å on 177 Cα
atoms; SI Appendix, Fig. S6B) (34), AfRho1 contains a Switch I
region predicted to bind to the GEF domain, a helical Switch II
region reported to participate in protein–protein complexes with
specific GTPase activators (35), and the canonical Rho GTPase
three-turn insertion helix (residues 124 to 134) involved in in-
teractions with, and subsequent activation of, downstream pro-
teins (36) (Fig. 4C and SI Appendix, Fig. S6C). Nucleotide-induced
conformational changes in the switch I/II regions of GTPases are
known to modulate the interactions with their effectors. Although
superposition of the AfRho1 GTPγS/GDP complexes gives an
overall rmsd fit of 0.8 Å over 150 aligned Cα atoms, the Switch I
and Switch II regions undergo conformational changes (maximum
Cα shifts of 8 Å with 47° rotation and 7 Å with 70° rotation, re-
spectively; Video S1).
In absence of an experimental AfRho1–AfRom2 CNH com-
plex, we took advantage of structural similarities of the individ-
ual AfRho1 and AfRom2 CNH structures to components of the
canonical G-heterotrimeric transducin complex structure, a
master regulator of the G protein coupled receptors known to bind
and regulate Rho guanine nucleotide exchange factors (Protein
Data Bank [PDB]: 1GOT) (35). We superposed the AfRom2 CNH
domain onto β-transducin (rmsd = 3.2 Å on 338 Cα atoms) and
AfRho1 onto α-transducin (rmsd = 2.6 Å on 177 Cα atoms)
(Fig. 4D). In this model, the AfRho1 α-helical Switch II motif in-
teracts with AfRom2 CNH similarly to the interaction in the
G-heterotrimeric transducin complex between the Gα GTPase and
the Gβ β-propeller subunits that facilitates the activation of the
signaling G protein by GDP to GTP exchange in the Gα subunit
(35). The electrostatic interaction that bridges the Gα Switch II
region to the β-propeller domain (Gα Glu212 to Gβ Lys57) is
conserved in our homology model (Asp76 of AfRho1 to Arg877 of
AfRom2 CNH) (Fig. 4D). Additional interactions found in the
G-heterotrimeric complex, such as the hydrogen bonds between
β-transducin Asn119 and α-transducin Gln200 or β-transducin
Thr143 to α-transducin Arg201, are mimicked in the model of the
complex by the pairs AfRom2 CNH His968 to AfRho1 Tyr66 and
AfRom2 CNH Lys987 to AfRho1 Glu64, respectively (Fig. 4D).
Interestingly, AfRho1 lacks the long Gα N-terminal helix that
interacts with the lateral face of the Gβ propeller. In the model
of the AfRho1–AfRom2 CNH complex, the equivalent interact-
ing interface is occupied by the unique AfRom2 CNH L1 loop
(Fig. 4D and SI Appendix, Fig. S7). Therefore, in our model, the
presence of the L1 loop together with the lack of an additional N
terminus helix in AfRho1 restricts the AfRho1–AfRom2 CNH
complex interface to the flat surface of the CNH and the AfRho1
Switch II region. Taken together, these analyses suggest that the
Switch II region is a potential interacting element in the
AfRho1–AfRom2 CNH complex.
Discussion
The CNH domain is a C-terminal motif of unknown function
present in fungal Rom2 GEF proteins that are essential for cell
wall biogenesis (19, 37, 38). CNH domains are also present in the
citron kinases from which they take their name (39), sharing less
than 20% sequence identity with the fungal CNH domains, but
are absent from the human Rom2 GEF orthologs. Therefore,
Table 1. Data collection and refinement statistics
SeMet AfRom2CNH AfRom2CNH_native AfRho1-GDP AfRho1-GTPγS
Space group P 21 21 2 P 21 21 2 P 43 P 21 21 2
a, b, c (Å) 77.0, 92.3, 52.3 78.0, 93.7, 52.6 53.8, 53.8, 62.7 37.2, 65.8, 75.0
Wavelength (Å) 0.97961 0.92818 0.98854 1.54178
T (K) 100 100 100 100
Resolution range (Å) 59.1–2.4 45.9–2.0 100.0–1.4 30.1–2.5
Unique reflections 15,324 (1,415) 174,698 (13,083) 140,126 (7,474) 6,797 (751)
Mean I/σ(I) 17.5 (2.3) 17.4 (1.3) 18.8 (1.6) 6.3 (3.9)
Multiplicity 2.0 (2.0) 4.0 (4.0) 4.1 (2.2) 6.6 (6.6)
Completeness (%) 100 (100) 99.9 (100) 99.0 (96.8) 100 (100)
R-merge 0.04 (0.30) 0.02 (0.57) 0.04 (0.34) 0.18 (0.35)




† 0.31/0.36 0.22/0.26 0.15/0.18 0.20/0.26
Number of nonhydrogen atoms 2,526 1,438 1,606
Macromolecules 2,434 1,404 1,414
Ligands 0 34 33
Solvent 111 211 159
Protein residues 310 181 182
B-factor (Å2)
Macromolecules 56.45 24.81 19.33
Ligands 42.07 19.67 10.60
Solvent 52.70 25.64 22.05
rms deviations
rms (bonds) 0.017 0.018 0.016
rms (angles) 2.01 2.04 1.83
PDB code 5O51 5ZVP 6JIK
Value for the highest resolution shell is shown in parentheses.
*Rwork = ΣhjjFobsj − jFcajcjj/ΣhjFobsj, where Fcalc and Fobs are the observed and calculated structure factors for the reflection h.
†Rfree = is equivalent to Rwork calculated with 5% of flagged reflections not used in refinement.
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due to the low sequence identity between fungal and human
CNH domains, it is a potential target for the development of
selective antifungal compounds. To test this hypothesis, we used
the opportunistic fungus A. fumigatus deletion mutant rom2Δcnh
as a model to dissect the function of the fungal CNH domain.
This mutant has a severe cell wall defective phenotype that
correlates with the previously reported cell wall defects for the
conditional rom2 knockdown mutants (19, 37). Phenotypes of
our rom2Δcnh strain include cytoplasm leakage and cell lysis, two
observations previously reported for the budding yeast condi-
tional Rho1 mutant (17). AfRom2 localizes to the cell membrane
in the hyphal tips where the new cell wall is synthesized and is
known to interact with the critical cell wall regulator AfRho1 (19,
28). In agreement with Dichtl et al. (28), our data indicate that
the localization of AfRom2 in the membranes is driven by the
CNH domain, whereas deletion of the CNH domain induces
Rom2 membrane dissociation. Thus, the lack of the CNH do-
main may negatively affect the Rom2–Rho1 interaction. The
complete inactivation of Rho1 in budding yeast or Rom2 in
Aspergillus induces lethality (17, 19). While the rom2Δcnh strain
shows retarded growth, lethality is only achieved in the presence
of cell wall–perturbing agents (Fig. 3A). This observation, which
is similar to the reported conditional Afrom2 knockdown phe-
notype (19), suggests a link between the CNH domain, Rho1,
and the CWI signaling pathway, which needs both proteins to
maintain CWI under stress conditions.
Upon activation by Rom2 GEF, Rho1 participates primarily in
the regulation of the fungal cell wall composition in response to
stress by directly modulating the activity of the membrane-bound
1,3-β-GS complex (40). In line with this, analysis of our
rom2Δcnh mutant cell wall ultrastructure by electron microscopy
(EM) revealed a 20-fold reduction thickness of the cell wall middle
layer due to a reduction in β-glucan (Fig. 3B). This reduction in 1,3-
β-glucan may be a consequence of reduced GS activity due to the
inability of the AfRom2ΔCNH protein to colocalize in the mem-
branes and activate enough Rho1. This observation correlates with
the previously reported S. cerevisiae conditional Rho1 knockout
strains (7, 16). We therefore propose that the AfRom2 CNH do-
main is essential for the production of 1,3-β-glucan via Rho1
activation.
Furthermore, in our pull-down experiment using the isolated
CNH domain as bait, we identified several components of the
Fig. 4. Crystal structures of AfRom2 CNH, AfRho1, and a model of their complex. (A) Cartoon representation of the AfRom2 CNH domain structure. Blades and
strands are labeled according to the nomenclature commonly used for the β-propeller proteins. Each blade has been colored differently for clarity. The additional
CNH domain loops L1, L2, and L3 are indicated. (B) 90 degrees rotation of the CNH domain. (C) Cartoon representation of the AfRho1 structure in complex with
GDP. Nucleotides and magnesium are shown as sticks and spheres, respectively. (D) Model ofAfRho1–AfRom2 CNH domain complex produced by superposition of
AfRho1 and AfRom2 CNH onto α and β transducin, respectively. The transducin heterotrimer (PDB 1GOT) is shown for comparison. AfRom2 CNH blade coloring
follows the same pattern as in A. The AfRho1 Switch II helix is colored red. The main predicted protein–protein interactions discussed in the main text are labeled.
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CWI signaling pathway reported to interact with Rom2, such as
Fks1, MidA, and Rho1 (19). The direct interaction of the isolated
AfRom2 CNH domain with AfRho1 under saturating nucleotide
concentrations was determined to be in the midmicromolar range
(Kd = 200 μM), up to three times weaker than the weakest
reported GEF-GTPase interaction [range of Kd = 0.2 to 77 μM
(41)]. In absence of nucleotide, Rho1 interacts with the isolated
AfRom2 CNH domain with an affinity of Kd = 80 μM. Taken
together, we propose that the AfRom2 CNH domain functions as
an interactor of AfRho1, acting as a critical element in cell wall
biogenesis mediated by the CWI pathway. In addition to the
classical CWI pathway, S. cerevisiae Rho1 is known to participate
in remodeling of the cell wall by regulating actin cytoskeleton
polarization (42). It is worth noting that several proteins involved
in actin regulation, such as End3, the actin-related protein 4, and
Pan1, are detected among the CNH-interacting proteins. It is
possible that in addition to its role in the CWI pathway, the CNH
domain may affect actin polarization or, as was proposed by Dichtl
et al. (17), the actin regulation proteins may interact with Rho1
and thus coelute in our pull-downs.
To understand the molecular mechanisms underpinning the
AfRho1–AfRom2 CNH interaction, we first tried to determine
the crystal structure of the complex of AfRho1 with the CNH
domain of AfRom2. This was unsuccessful, possibly as a result of
the relatively weak (midmicromolar) interaction or the destabi-
lization by the high salt conditions used in crystallization screens
(43). We also attempted cryo-electron microscopy, but the small
size of the AfRho1–AfRom2 CNH complex precluded identifi-
cation of suitable particles in EM grids. In addition, although we
had direct evidence of the Rho1–Rom2 interaction, our BLI
experiment does not show a difference in binding between the
active Rho1 (GTP complexed) and the relaxed Rho1 (GDP
complexed), which, in agreement with the data published for the
Drosophila Rom2 CNH ortholog Sticky (25), indicates that in-
teraction with the CNH domain does not depend on the Rho1
conformational state and might instead play a scaffolding role in
the Rom2–Rho1 interaction.
To shed light on the nature of the interaction, we first obtained
the AfRom2 CNH crystal structure, revealing that it possesses a
seven-bladed β-propeller fold. Many β-propeller proteins are known
to have a flat surface that is used to establish electrostatic interac-
tions with their interactors (44, 45). In pull-down experiments, the
isolated AfRom2 CNH domain appears to recruit a large number of
proteins that, in absence of further validation, may not necessarily
act as AfRom2 interactors. Despite this observation, the CNH
structure is remarkably similar to the extensively characterized
heterotrimeric G protein Gβ subunit that binds the Gα GTPase
subunit in the presence of GDP, which allowed us to predict the
putative CNH interaction surface. In the proposed model of the
AfRho1–AfRom2 CNH interaction, equivalent stabilizing interac-
tions are mediated by the AfRho1 Switch II motif (46). Interest-
ingly, similar to the findings reported for the Drosophila Rom2
CNH ortholog Sticky, the observed interactions are not affected by
the switch II conformational changes upon nucleotide exchange
(25). The lack of additional anchoring points, although unexpected,
has previously been observed in protein–protein interactions for
other β-propeller proteins. For example, the non-GTPase protein
Laminin establishes a complex with the six-bladed β-propeller
Nidogen (PDB 1NPE) that is only stabilized by the packing of
a Laminin Switch II–like loop with the surface of the Nidogen
β-propeller blades 2 and 3 (SI Appendix, Fig. S7) (47). Taken to-
gether, the model suggests that the AfRho1 Switch II region is the
primary mediator of the AfRom2 CNH–AfRho1 interaction.
The multilayered cell wall is a structure unique to fungi and
absent in human cells. Targeting fungal cell wall biosynthetic
pathways is thought to be a promising strategy for the development
of new antifungal agents. In this work, we have identified a critical
stabilizing motif conserved in all fungi, the CNH domain, essential
for the molecular crosstalk between Rho1 and Rom2 as part of the
CWI pathway. The data presented here show that the presence of
the Rom2 CNH domain is required for proper Rho1 localization.
Deletion of the Rom2 CNH domain has severe consequences for
the CWI signaling pathway, including the disruption of the CWI,
leading to cell lysis under stress conditions. Both AfRho1 and
AfRom2 are potential antifungal targets, as their knockouts induce
lethal phenotypes (17, 19). However, AfRho1 is almost identical to
its human ortholog HsRhoA, with both proteins sharing a nearly
fully conserved active site (34). HsRhoA is ubiquitous and mediates
the cytoskeletal response to external signals in human cells (34).
Deficiencies in HsRhoA are not compatible with life (48). Thus,
selectively targeting AfRho1 may be difficult and prone to adverse
consequences due to collateral inhibition of HsRhoA. However,
due to the low degree of conservation between fungal and human
CNH domains, targeting this domain or the CNH-Rho1 Switch II
binding interface could be a strategy to disrupt CWI signaling.
Future work will be needed to explore whether the CNH-Rho1
interface can be specifically targeted.
Materials and Methods
Strains and Growth Conditions. The A. fumigatus strain KU80Δ was used for
phenotypic analysis (49). The parental strain for genetic manipulation,
KU80ΔpyrG− (49), was propagated at 37 °C on solid MM (50) supplemented
with 5 mM uridine and 5 mM uracil. Conidia were prepared by propagating
strains on solid medium for 72 h at 37 °C. The spores were collected with 0.1%
(vol/vol) Tween 20 in physiological saline, washed twice, and resuspended in
sterile water. Conidial concentration was confirmed using a hemocytometer
and viable cell counting. Mycelium were obtained by inoculating strains in
liquid medium and incubating at 37 °C with shaking at 200 rpm. At a specified
timepoint, the mycelia were harvested, washed with sterile water, frozen in
liquid nitrogen, and ground up using a mortar and pestle. All plasmids were
propagated in Escherichia coli DH5α cells (Bethesda Research Laboratories).
Construction of the rom2Δcnh Mutant. Plasmid 434 (51) was obtained from
the Fungal Genetics Stock Center (FGSC) and used as an Afrom2 gene carrier
backbone in the construction the rom2 cnh deletion mutant. The gfp and
pyrG selection markers were amplified from plasmid pHL83 (52) (obtained
from FGSC) with primers P1, containing a XbaI restriction site, and P2, con-
taining a SpeI restriction site (Table 2). The rom2 cnh domain 5′ flanking
region (1674-2724) and a noncoding region of rom2 (1,000 bp) were am-
plified from plasmid 434 with primers P3 and P4 and primers P5 and P6,
respectively (Table 2). The PCR product of cnh 5′ flanking region (1,050 bp)
and the rom2 downstream noncoding region were cloned by a restriction-
less method (53) into the upstream and downstream regions of the plasmid
434 fusion cassette to create plasmid rom2 (1674-2724) gfp-pyrG+ (Fig. 2A).
Following DNA sequence verification, rom2(1674-2724)-gfp-pyrG+ was
transformed into A. fumigatus KU80ΔpyrG− by polyethylen glycol (PEG)-
mediated fusion of protoplasts (54). Positive transformants were selected by
uridine/uracil autotrophy and verified by PCR and western blot analysis. For
PCR confirmation, a pair of primers P7 and P8 were used to amplify the cnh
region (rom2C) of the rom2 gene. The product was obtained from the pa-
rental strain but not from the mutant, suggesting the successful deletion of
the cnh coding region in the rom2 gene. Primers P9 and P10 were used to
amplify the gfp-pyrG cassette from the mutant but not from the parental
strain, demonstrating that the gfp-pyrG cassette has been incorporated into
the genomic DNA of the mutant. Primers P11 and P12 were used to amplify
a region from the rom2 gene (1.4 kb upstream of cnh) to the 5′ region of the
gfp-pyrG cassette (493 bp at the 5′ region). The product was only obtained
from the mutant but not from the parental strain. Furthermore, primers P13
and P14 were used to amplify the region from 3′ of the gfp-pyrG (526 bp)
cassette to the downstream 1.5 kb of cnh. Again, the product was only
obtained from the mutant but not from the parental strain. Primer pairs of
P11-P12 and P13-P14 were used to demonstrate that the gfp-pyrG cassette
has been incorporated into the correct locus in the A. fumigatus genome. To
further validate the mutant, Southern blotting was conducted. Using the
left homologous region as probe and NcoI digestion of genomic DNA, the
hybridization band of the mutant (1,628 bp) was expected and different
from the band of the parental strain (1,853 bp), demonstrating the single
correct integration of the deletion cassette at the CNH domain locus.
Conidia from the mutant and the parental strain (negative control) were
inoculated in 10 mL of YEPD (2% yeast extract, 2% glucose, and 0.1%
peptone) and cultured in a flask rotator at 37 °C for 48 h. Cell extracts were
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prepared by homogenizing the mycelia using liquid nitrogen in lysis buffer
(50 mM Tris/HCl pH 7.5, 150 mM NaCl, 50 mM KCl, 0.01% Triton X-100, 1 mM
phenylmethylsulfonyl fluoride (PMSF), and 1:100 protease inhibitor mix-
ture). Cell lysates were centrifuged at 5,000 rpm for 30 min to eliminate cell
debris, and then supernatants were further centrifuged at 7,000 rpm for
10 min at 4 °C. Total protein extracts were quantified by the Bradford
method and further examined for the presence of recombinant proteins by
10% sodium dodecyl sulphate–polyacrylamide gel electrophoresis
(SDS-PAGE) followed by western blotting using a GFP antibody. A control
strain expressing gpd-gfp was used as GFP-positive control.
Analysis of the rom2Δcnh Mutant. One hundred conidia from the rom2Δcnh
mutant and the parental strain were inoculated onto solid YEPD medium
and incubated for 48 h at 37 °C, examined, and photographed. To test the
rom2Δcnh mutant sensitivity to chemical reagents, serial dilutions of conidia
from 107 to 104 were spotted on solid MM (50) containing 50 μg/mL of
Calcofluor White, 50 μg/mL Congo Red, 50 μg/mL sodium dodecyl sulphate
(SDS), 2.5 μg/mL caspofungin, and 10 μg/mL hygromycin B, respectively. After
incubation at 37 °C for 48 h, the plates were photographed. Three inde-
pendent experiments were performed.
To examine the ultrastructure of the cell wall, mycelia grown in solid MM
medium were fixed and examined with an H-600 electron microscope, as
described previously (55). For the chemical analysis of the cell wall, conidia
were inoculated into 100 mL MM liquid medium and incubated at 37 °C with
shaking at 200 rpm for 48 h. The mycelia were harvested, washed with
sterile water, and stored at −80 °C. The cell wall components were isolated
and assayed as described previously (56). Three samples of lyophilized my-
celia were used for cell wall analysis from each strain, and three indepen-
dent experiments were performed.
Construction of the gfp-cnhMutant. Plasmid p434 (51) was used as a backbone
construct. A gfp and rom2 cnh domain (2725-3792) fusion cassette was made
and landed with primers P15 and P16 restrictionless into p434 after the gpd
promoter to induce expression (27) (Table 2). The resulting plasmid gpd-gfp-
rom2 (2725-3792) was transformed into A. fumigatus KU80ΔpyrG− by PEG-
mediated fusion of protoplasts (54). Positive transformants were selected by
uridine/uracil autotrophy. The presence of the gpd-gfp-rom2 (2725-3792)
insertions was evaluated by amplifying a 480 bp region of the mutant with
PCR primers P17 and P18 (Table 2). Further confirmation in conidia was
performed by western blot as described for the rom2Δcnh mutant.
GFP Fluorescence Localization Imaging. To determine the localization of the
GFP-AfRom2, GFP-AfRom2ΔCNH, and CNH domain under the gpdA pro-
moter, the selected strains (1 × 103 conidia in 1 mL of liquid MM) were
grown in eight-well cell culture plates (Thermo Scientific) with a cover glass
sitting in the bottom of the well. Live fluorescence imaging was recorded
after 13 h incubation at 37 °C with a fluorescence Zeiss Axio Imager M1
equipped with an Axiocam Icc1 and an Axiocam MRM (Carl Zeiss GmbH).
Protein Extraction and GFP-Trap Affinity Purification. The A. fumigatus strain
expressing the gpd-gfp-cnh fusion construct and a control strain expressing
gpd-gfp were grown in YEPD liquid medium with agitation for 24 h at 37 °C.
A. fumigatus cells were collected by filtering through a Miracloth (Millipore)
and dried. Cell extracts were prepared by homogenizing the mycelia,
resuspended in lysis buffer (50 mM Tris/HCl pH 7.5, 150 mM NaCl, 50 mM KCl,
0.01% Triton X-100, 1 mM PMSF, and 1:100 protease inhibitor mixture) using
liquid nitrogen. Total cell lysates were centrifuged for 30 min at 5,000 rpm to
eliminate cell debris before a further centrifugation at 7,000 rpm for 10 min
at 4 °C was performed. Total soluble protein concentration was determined
by Bradford and then diluted to ∼10 mg/mL before the GFP-Trap affinity
purification (Chromotek). GFP-Trap resin (25 μL) was equilibrated in 400 μL
of ice-cold dilution buffer (10 mM Tris/HCl pH 7.5, 150 mM NaCl, 0.5 mM
EDTA, 1 mM PMSF, 1:100 protease inhibitor mixture) by washing three times
according to the manufacturer’s instructions. The GFP-Trap resin was then
resuspended in 100 μL of ice-cold dilution buffer, mixed with cell lysate, and
incubated for 2 h at 4 °C with gentle agitation. The suspension was centri-
fuged at 2,000 rpm for 10 min at 4 °C, and the pelleted GFP-Trap beads were
washed twice with 500 μL of wash buffer (10 mM Tris/HCl pH 7.5, 350 mM
NaCl, 0.5 mM EDTA, 1 mM PMSF, 1:100 protease inhibitor mixture). Bound
proteins were extracted in 100 μL glycine pH 2.5 and centrifuged at
2,000 rpm for 2 min at 4 °C. Prior to mass spectrometry, the eluted proteins
were separated and analyzed in 10% SDS-PAGE gels.
Mass Spectrometry and Data Analysis. Samples from the gfp-cnh over-
expression mutant and the gfp overexpression mutant were run on a 10%
Table 2. PCR primers used in this study
Primer Sequence (5′ to 3′)
P1 5′ AAATCTAGAATGAACAAGACAGTTTTGTGTTCAATTTTTTC 3′
P2 5′ CTGTCTGAGAGGAGGCACTGATG 3′
P3 5′ CATCACCGAATTCTGGCAATGTCTAGAGTGTTCGGAAATTGCTTGGAAGTT
CTG 3′





P7 5′ CACTCCCAATACTATCCTCTTGCGC 3′
P8 5′ GGCTTGTTCCAGAAATCCAGACTGGC 3′
P9 5′ GGAGCTGGTGCAGGCGCTGGAGC 3′
P10 5′ CTGTCTGAGAGGAGGCACTGATGCG 3′
P11 5′ CGATGTGACGTACGATCATCGACTTC 3′
P12 5′ CTTGTCGGCCATGATGTATACGTTGTG 3′
P13 5′ GGACAGCAATACCAGACTCCTGCATC 3′
P14 5′ GCAGTGGTCACGATTCCTCTATGAAC 3′
P15 5′ CATCACCGAATTCTGGCAATGTCTAGAatgAGTAAAGGAGAAGAACTTTTC
ACTGG 3′
P16 5′ GAGCATTGTTTGAGGCGACCGGTTTACTTGTTCCAGAAATCCAGACTGGC 3′
P17 5′ CGCCAAGGCTTTATCTATGTAG 3′
P18 5′ TCCCATGAGATCTTCCAATCCG 3′
P19 5′ CAGTCTGGATTTCTGGAACAAGTAACAACAACAACAATGAGCGGCC 3′
P20 5′ GGCCGCTCATTGTTGTTGTTGTTACTTGTTCCAGAAATCCAGACTG 3′
P21 5′ CTGGGATCCATGGCTGAATCCGCCGCAAGC 3′
P22 5′ GATGCGGCCGCTCATCAGTGGGTCTTGGTCAAGAGAGCAG 3′
P23 5′ CTGGGATCCAACAAGACAGTTTTGTGTTCAAATTTTTTC 3′
P24 5′ GATGCGGCCGCTCATTGTTGTTGTTGGGGCTTGTTCC 3′
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SDS-PAGE gel and stained with InstantBlue (Expedeon) Coomassie stain.
After thoroughly washing with mass spectometry (MS) grade water (VWR
International), each lane on the gel was excised by cutting 1-mm cubes with
a sterile scalpel. In-gel digestion and peptides extraction was performed as
previously described (57). Each sample (15 μL) was injected for the liquid
chromatography–mass spectrometry experiments, which were performed on
an Ultimate 3000 RSLCnano System (Dionex- Thermo Scientific) coupled to
an LTQ OrbiTrap Velos (Thermo Scientific). The Mascot search engine
(Mascot Daemon Version 2.3.2) was used to analyze the data against the A.
fumigatus proteome (from UniProt, Neosartorya fumigata [strain ATCC
MYA-4609/Af293/CBS 101355/FGSC A1100] [A. fumigatus], December 2019).
GO analyses were run using GO Slim Mapper (58) and FungiFun 2.2.8 (59).
Protein Expression and Purification of AfRom2CNH and AfRho1. Recombinant
His6-Rom2 CNH (862-1194) was cloned into a noncleavable 6His version of
the expression vector pGEX6P1 (GE Healthcare) by using restriction enzymes
BamHI and NotI and primers P23 and P24. Then, the C terminus was trun-
cated using the P20 and P19 primers (Table 2). Recombinant AfRho1 (resi-
dues 1 to 181) was cloned into the expression vector pGEX6P1 (GE Healthcare)
using restriction enzymes BamHI and NotI and primers P21 and P22 (Table 2). A
F25N mutation was introduced in AfRho1 for protein stability, as described
previously (60, 61). Both expression constructs were transformed into E. coli
BL21 (non-DE3) cells and plated onto solid Luria Bertani (LB) media supple-
mented with ampicillin. Positive clones from each construct were inoculated in
100 mL of liquid LB and let them grow overnight at 37 °C in constant agitation.
Then, 10 mL of each starter culture was inoculated into 1 L of LB and grown at
37 °C until reaching OD600 of 0.8, then protein expression was induced with
250 μM IPTG at 25 °C for 16 h. Induced cultures were harvested by centrifu-
gation at 4,000 rpm at 4 °C for 30 min in a J6-MI centrifuge (Beckman Coulter).
Pellets were resuspended in Tris-buffered saline (TBS)) buffer supplemented
with 0.5 mM Tris(2-carboxyethyl)phosphine (TCEP) and protease inhibitor
mixture (1 mM benzamidine, 0.2 mM PMSF, 5 μM leupeptin) and then lysed by
using pressure homogenization with an EmulsiFlex cell disruptor (15,000 kPa;
Avestin). This was followed by one step of centrifugation at 16,000 rpm for 1 h
using an Avanti J26S centrifuge (Beckman Coulter). Recombinant AfRom2 CNH
was enriched by incubating supernatants with His-Nickel beads equilibrated in
TBS buffer (GE Healthcare) at 4 °C on a rotating platform for 2 h. Beads were
washed five times with TBS to remove nonspecifically binding proteins, and
then recombinant AfRom2 CNH protein was eluted by using a 10 to 250 mM
imidazole gradient.
Recombinant GST-tagged AfRho1 protein was enriched by using the same
procedure described for AfRom2 CNH but using Glutathione-Sepharose
beads 4B (GE Healthcare) instead of nickel beads. Recombinant AfRho1
was recovered from the beads by the GST tag cleavage with the addition of
200 μg of PreScission protease at 4 °C overnight in a rotatory shaker.
Eluted proteins were concentrated to 5 mL (AfRom2 CNH) or 2 mL
(AfRho1) using a 10 kDa cutoff Vivaspin concentrator (Amersham Bioscience)
and further purified by size exclusion using a Superdex 200 column for
AfRom2 CNH or a Superdex 75 column for AfRho1 (GE Healthcare). Both
columns were previously equilibrated in purification buffer (50 mM Tris,
150 mM NaCl, 0.5 mM TCEP). Proteins were eluted at a flow rate of 1 mL/min
in the same buffer using an AKTA prime FPLC system (GE Healthcare). The
presence of recombinant protein was confirmed by SDS-PAGE. Fractions
containing protein were pooled and concentrated to 2 mg/mL using a
10 kDa cutoff Vivaspin concentrator (GE Healthcare) and then frozen in
liquid nitrogen and finally stored at −80 °C until further use.
Crystallization, Data Collection, and Structure Determination. AfRom2 CNH
and SeMet derivative crystals were grown by vapor diffusion from solutions
containing 0.2 μL protein (2 mg/mL) and 0.2 μL of Morpheus H10 condition
(Molecular Dimensions) as a precipitant. Crystals were then mounted in
nylon loops and flash frozen in liquid nitrogen. Native diffraction data sets
were collected at the Diamond Light Source I03 beamline (Harwell), while
AfRom2 CNH SeMet derivative datasets were collected at the European
Synchrotron Radiation Facility (ESRF) ID30A-3 beamline (ESRF).
AfRom2 CNH and SeMet derivative crystals both belonged to the P21 212
orthorhombic space group with similar unit cell dimensions. Diffraction data
sets were processed using XDS (62) and then merged and scaled with Aimless
(63). Experimental phases were obtained from the derivative data by Sele-
nium Single-wavelength anomalous diffraction (Se-SAD) phasing with the
AutoSol and Autobuild options in PHENIX program suite (64). This was fol-
lowed by iterative cycles of manual model building in COOT (65) and
structure refinement with REFMAC5 (66). The native AfRom2 CNH structure
was solved by molecular replacement using the SeMet AfRom2 CNH model
in MOLREP (67, 68). Refmac5 (67) was used for further refinement followed
by manual model building with COOT (65). All data collection and refine-
ment statistics are presented in Table 1. Figures depicting the protein
structure were generated using PyMOL (69).
AfRho1 crystals were grown by vapor diffusion from solutions containing
0.2 μL protein (20 mg/mL) and 0.2 μL of precipitant consisting of 37.1% wt/
vol PEG 5000 MME, 150 mM Tris pH 8.0, and 40 mM magnesium sulfate, plus
GDP or GTPγS phosphonucleotides as required. Crystals were mounted in ny-
lon loops and flash frozen in liquid nitrogen, and datasets were collected in
the beamline ID30A (ERSF) (GDP) or by using our in-home Rigaku source
(GTPγS). Datasets were indexed and integrated using iMosflm (70, 71) and
then merged and scaled by Aimless (63). AfRho1 protein complexed with GDP
crystallized into the tetragonal space group P43, while the GTPγS complex
crystallized into the P21 212 orthorhombic space group. In both cases, a single
molecule was present in the asymmetric unit. AfRho1 structures were solved
by molecular replacement using MOLREP (72) with the HsRhoA structure (PDB
ID 1FTN) (34) as the phase donor. This was followed by iterative cycles of
manual model building in COOT (65) and structure refinement with REFMAC5
(66, 73). Data collection and refinement statistics are presented in Table 1.
Figures depicting the protein structures were generated using PyMOL (69).
BLI Binding Affinity Measurements. BLI was used to measure the binding af-
finities of AfRho1 protein with/without GDP/GTPγS nucleotides to AfRom2
CNH. To achieve this, a solution of 1 mg/mL of AfRom2 in reaction buffer
(25 mM Hepes, 150 mM NaCl, 0.5 mM TCEP pH 7.5) was biotinylated using
the EZLink NHS-Peg4-Biotin reagent (Thermo Scientific) according to the man-
ufacturer’s instructions. Excess of biotin was removed with a 2 mL Zeba spin
desalting column (Thermo Scientific). An Octet Htx (Forte Bio) was used for
measuring the AfRom2 CNH− apo AfRho1 interaction, and an Octet Red 384
system (Forte Bio) was used for measuring the AfRom2 CNH− AfRho1-GDP and
AfRom2 CNH− AfRho1-GTP interactions. Briefly, sensors were coated in each
Octet system with the biotinylated AfRom2 CNH and binding experiments per-
formed. The optimal AfRom2 concentration required to coat the super strep-
tavidin (SSA) biosensors, previously soaked in reaction buffer for this experiment,
was 30 μg/mL. To block any free SSA streptavidin sites and avoid potential un-
specific signals, a further incubation for 120 s with biocytin was required. As a
reference control for the experiment, a new set of SSA sensors not exposed to
AfRom2 CNH were blocked with biocytin following the same procedure.
The AfRho1–AfRom2 binding consisted of a six-point concentration-
dependent series commencing at 1 mM in threefold serial dilutions mea-
sured in three steps: 1) 60 s baseline determination in assay buffer, 2) 60 s
association in each concentration, and 3) 120 s of dissociation step in assay
buffer. The entire experiment was repeated with the control (reference)
sensors. Data were processed and visualized using proprietary Octet software
specific for each Octet machine, and the response rate was determined by
subtracting the baseline and reference responses. Binding isotherms were fit
using Octet software to determine the dissociation constant (Kd). The Kd value
was double referenced by applying global, steady-state, and partial fits (where
appropriate).
Data Availability. The atomic models have been deposited in the PDB Da-
tabase under the accession nos. 5O51, 5ZVP, and 6JIK).
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